Latest Biotech News

Innovative computational methods are elevating biomedical analysis. Researchers at Virginia Commonwealth University developed TACIT, an AI algorithm enabling rapid, high-precision cell type...

Sustainability-focused research reveals promising advances. University of Nottingham discovered surface patterns that resist bacterial colonization on plastics, with implications for preventing...

Sarepta Therapeutics faces heightened scrutiny after reporting a second patient death linked to its gene therapy Elevidys for Duchenne muscular dystrophy (DMD). Both fatalities involved acute...

Draig Therapeutics, a UK-based biotech emerging from stealth, secured a $140 million Series A funding round to advance its neuropsychiatry pipeline. The financing, backed notably by Sanofi's...

Sarepta Therapeutics has halted shipments of its gene therapy Elevidys for Duchenne muscular dystrophy in older, non-ambulatory patients following a second reported death linked to acute liver...

Insilico Medicine announced the design of novel pan-KRAS inhibitors through its Chemistry42 AI platform, overcoming challenges associated with KRAS’ undruggable nature. Utilizing structure-based...

Eli Lilly announced its acquisition of Verve Therapeutics for up to $1.3 billion, integrating Verve's gene-editing technology targeting cardiovascular disease into its pipeline. Verve's lead...

Researchers utilizing single-cell RNA sequencing and spatial transcriptomics disclosed immune cell subsets implicated in the clinical variability of systemic sclerosis. Specific monocyte and CD8+...

The University of Hong Kong developed a dual checkpoint inhibitor therapy combining nivolumab and ipilimumab for unresectable hepatocellular carcinoma, receiving authorization across multiple...

Calibr-Skaggs launched the first-in-human clinical study testing a modular 'switchable' CAR-T therapy platform designed to improve control and safety in solid tumor treatments. The Phase 1 trial...

Yale University researchers developed an enhanced multiplex genome editing technique, significantly increasing the number of accurate edits per cell while minimizing off-target mutations. This...

Rice researchers, led by Junichiro Kono, engineered a novel photonic-crystal cavity integrating lightly doped indium antimonide to preferentially enhance vacuum fluctuations of circularly...

Stanford scientists discovered missing enzymes critical for the biosynthesis of taxol, a vital chemotherapy drug sourced from yew trees. Utilizing single-nucleus RNA sequencing on stressed yew...

Eli Lilly has agreed to acquire Verve Therapeutics for up to $1.3 billion, including milestone payments contingent on clinical progress. Verve’s lead gene-editing candidate, VERVE-102, targets...

Sarepta Therapeutics faces heightened scrutiny following a second death due to acute liver failure associated with its gene therapy Elevidys, approved for Duchenne muscular dystrophy. Both...

Insilico Medicine has announced the discovery of novel pan-KRAS inhibitors through its AI-powered generative platform Chemistry42. Combining structure-based drug design and scaffold hopping, the...

Recent studies report remarkable immunotherapy responses in subsets of pancreatic cancer patients treated solely with immune checkpoint inhibitors, exhibiting unprecedented progression-free...

Multiple AI-driven initiatives are reshaping biotech research and diagnostics. Xaira Therapeutics has released an expansive Perturb-seq dataset to accelerate virtual cell modeling and AI drug...

Isomorphic Labs, an Alphabet-backed AI drug discovery company, has hired its first U.S.-based chief medical officer and established an office in Cambridge to facilitate clinical advancement of...

The U.S. Food and Drug Administration unveiled a pilot priority review voucher program aiming to accelerate drug review times from up to a year down to as little as one month for treatments...